PT68126A - Process for preparing therapeutic agents derivatives of phthalazine - Google Patents
Process for preparing therapeutic agents derivatives of phthalazineInfo
- Publication number
- PT68126A PT68126A PT68126A PT6812678A PT68126A PT 68126 A PT68126 A PT 68126A PT 68126 A PT68126 A PT 68126A PT 6812678 A PT6812678 A PT 6812678A PT 68126 A PT68126 A PT 68126A
- Authority
- PT
- Portugal
- Prior art keywords
- phthalazine
- therapeutic agents
- preparing therapeutic
- derivatives
- agents derivatives
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical class C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2358277 | 1977-06-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT68126A true PT68126A (en) | 1978-07-01 |
Family
ID=10198020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT68126A PT68126A (en) | 1977-06-03 | 1978-06-01 | Process for preparing therapeutic agents derivatives of phthalazine |
Country Status (29)
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4370328A (en) * | 1977-11-03 | 1983-01-25 | Pfizer Inc. | Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines |
| IL59619A0 (en) * | 1979-03-28 | 1980-06-30 | Pfizer | Phthalazine derivatives,their preparation and pharmaceutical compositions containing them |
| CA1173037A (en) * | 1980-03-01 | 1984-08-21 | John L. Archibald | Piperidino ureas as antidepressants |
| GB8320958D0 (en) * | 1983-08-03 | 1983-09-07 | Pfizer Ltd | Quinazoline cardiac stimulants |
| US5001125A (en) * | 1984-03-26 | 1991-03-19 | Janssen Pharmaceutica N.V. | Anti-virally active pyridazinamines |
| US4882354A (en) * | 1987-12-16 | 1989-11-21 | Norwich Eaton Pharmaceuticals, Inc. | N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents |
| US5300515A (en) * | 1991-01-31 | 1994-04-05 | Kyorin Pharmaceutical Co., Ltd. | Carbamic acid derivatives and method for preparing the same |
| JP3169188B2 (ja) * | 1991-01-31 | 2001-05-21 | 杏林製薬株式会社 | カルバミン酸誘導体及びその製造方法 |
| EP0621267A1 (en) * | 1993-04-07 | 1994-10-26 | Shell Internationale Researchmaatschappij B.V. | Spiropiperidine derivatives and their use as fungicides |
| AU5772196A (en) * | 1995-05-19 | 1996-11-29 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
| CN1121220C (zh) * | 1996-08-20 | 2003-09-17 | 卫材株式会社 | 稠合哒嗪系化合物的勃起机能不全症治疗剂 |
| US20030186963A1 (en) | 2001-09-14 | 2003-10-02 | Dorwald Florencio Zaragoza | Substituted piperidines |
| RU2333210C2 (ru) * | 2002-08-16 | 2008-09-10 | Янссен Фармацевтика Н.В. | Соединения пиперидинила, селективно связывающие интегрины |
| US20040224986A1 (en) * | 2002-08-16 | 2004-11-11 | Bart De Corte | Piperidinyl targeting compounds that selectively bind integrins |
| US20060019975A1 (en) * | 2004-07-23 | 2006-01-26 | Pfizer Inc | Novel piperidyl derivatives of quinazoline and isoquinoline |
| TW200630337A (en) | 2004-10-14 | 2006-09-01 | Euro Celtique Sa | Piperidinyl compounds and the use thereof |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| US7678363B2 (en) | 2005-08-26 | 2010-03-16 | Braincells Inc | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs |
| EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| JP2009524637A (ja) * | 2006-01-27 | 2009-07-02 | ファイザー・プロダクツ・インク | アミノフタラジン誘導体化合物 |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| WO2007110449A1 (en) | 2006-03-29 | 2007-10-04 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use |
| TW200812963A (en) | 2006-04-13 | 2008-03-16 | Euro Celtique Sa | Benzenesulfonamide compounds and the use thereof |
| US8791264B2 (en) | 2006-04-13 | 2014-07-29 | Purdue Pharma L.P. | Benzenesulfonamide compounds and their use as blockers of calcium channels |
| EP2021000A2 (en) | 2006-05-09 | 2009-02-11 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| MX2008014320A (es) | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
| EP1903037A1 (de) * | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors |
| EP1900731A1 (de) * | 2006-09-07 | 2008-03-19 | Bayer Schering Pharma Aktiengesellschaft | N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren |
| EP2068872A1 (en) | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| WO2008124118A1 (en) | 2007-04-09 | 2008-10-16 | Purdue Pharma L.P. | Benzenesulfonyl compounds and the use therof |
| RU2010106974A (ru) | 2007-08-07 | 2011-09-20 | Ф.Хоффманн-Ля Рош Аг (Ch) | Ариловые эфиры пирролидина в качестве антагонистов рецепторов nk3 |
| ATE519738T1 (de) | 2007-08-22 | 2011-08-15 | Hoffmann La Roche | Pyrrolidinarylether als nk3-rezeptorantagonisten |
| CA2699464A1 (en) * | 2007-09-14 | 2009-03-19 | F. Hoffmann-La Roche Ag | Piperidine derivatives as nk3 receptor antagonists |
| WO2009040659A2 (en) | 2007-09-28 | 2009-04-02 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| AR077014A1 (es) * | 2009-06-19 | 2011-07-27 | Lilly Co Eli | Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer |
| EP2804603A1 (en) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Beta-cell replication promoting compounds and methods of their use |
| CN113087654B (zh) * | 2021-04-15 | 2022-12-23 | 苏州昊帆生物股份有限公司 | 哌啶-4-丁胺的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1094044A (en) * | 1965-07-12 | 1967-12-06 | Vantorex Ltd | Phthalazine derivatives |
| GB1199768A (en) | 1966-10-31 | 1970-07-22 | Pfizer & Co C | Nitrogen Heterocycles and process for their preparation |
| GB1293565A (en) * | 1969-05-03 | 1972-10-18 | Aspro Nicholas Ltd | Aminophthalazines and pharmaceutical compositions thereof |
| GB1460389A (en) | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
-
1978
- 1978-05-15 IN IN364/DEL/78A patent/IN148482B/en unknown
- 1978-06-01 FI FI781753A patent/FI781753A/fi not_active Application Discontinuation
- 1978-06-01 GR GR56414A patent/GR74402B/el unknown
- 1978-06-01 PT PT68126A patent/PT68126A/pt unknown
- 1978-06-01 JP JP6627978A patent/JPS5416488A/ja active Granted
- 1978-06-01 BE BE188257A patent/BE867727A/xx unknown
- 1978-06-01 IT IT24106/78A patent/IT1094944B/it active
- 1978-06-01 NZ NZ187453A patent/NZ187453A/xx unknown
- 1978-06-01 GB GB7826202A patent/GB2000136B/en not_active Expired
- 1978-06-01 IL IL54842A patent/IL54842A/xx unknown
- 1978-06-01 DE DE19782824064 patent/DE2824064A1/de not_active Ceased
- 1978-06-02 AR AR272434A patent/AR222013A1/es active
- 1978-06-02 SE SE7806519A patent/SE7806519L/xx unknown
- 1978-06-02 SU SU782624349A patent/SU856383A3/ru active
- 1978-06-02 AT AT0400878A patent/AT362792B/de not_active IP Right Cessation
- 1978-06-02 HU HU78PI629A patent/HU179745B/hu unknown
- 1978-06-02 PL PL1978217897A patent/PL116437B1/pl unknown
- 1978-06-02 FR FR7816545A patent/FR2392986A1/fr active Granted
- 1978-06-02 AU AU36839/78A patent/AU505373B1/en not_active Expired
- 1978-06-02 NO NO781935A patent/NO781935L/no unknown
- 1978-06-02 ZA ZA00783183A patent/ZA783183B/xx unknown
- 1978-06-02 NL NL7806016A patent/NL7806016A/xx not_active Application Discontinuation
- 1978-06-02 DK DK248078A patent/DK248078A/da not_active Application Discontinuation
- 1978-06-02 ES ES470470A patent/ES470470A1/es not_active Expired
- 1978-06-02 LU LU79761A patent/LU79761A1/fr unknown
- 1978-06-02 PL PL1978207337A patent/PL113208B1/pl unknown
- 1978-06-02 DD DD78205751A patent/DD137355A5/xx unknown
- 1978-06-02 PL PL1978217896A patent/PL116420B1/pl unknown
- 1978-06-02 CA CA304,700A patent/CA1111850A/en not_active Expired
- 1978-06-03 EG EG354/78A patent/EG13527A/xx active
-
1979
- 1979-03-01 ES ES478199A patent/ES478199A1/es not_active Expired
- 1979-03-01 ES ES478200A patent/ES478200A1/es not_active Expired
- 1979-03-01 ES ES478201A patent/ES478201A1/es not_active Expired
- 1979-06-18 SU SU792777649A patent/SU862826A3/ru active
- 1979-12-13 US US06/103,342 patent/US4289772A/en not_active Expired - Lifetime
-
1980
- 1980-02-12 AR AR279935A patent/AR223999A1/es active
- 1980-05-20 IN IN368/DEL/80A patent/IN149550B/en unknown
- 1980-06-10 AT AT0305080A patent/AT363096B/de not_active IP Right Cessation
-
1981
- 1981-01-13 IN IN19/DEL/81A patent/IN149973B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT68126A (en) | Process for preparing therapeutic agents derivatives of phthalazine | |
| PT68071B (en) | Process for preparing hydantoin therapeutic agents | |
| ZA775848B (en) | Therapeutic system for administering clonidine transdermally and process for making same | |
| RO75478B (ro) | Procedeu pentru prepararea unor derivati ai acidului alfa-fenoxipropionic | |
| GR65303B (en) | Process for preparation of phthalazin-4-ylacetic acid derivatives | |
| PT68733A (en) | Process for preparing therapeutic agents which are derivatives of quinazoline | |
| PT68834A (en) | Process for preparing therapeutic agents | |
| PT67164A (en) | Process for the preparation of hydantoin derivatives as therapeutic agents | |
| PT68734A (en) | Process for preparing therapeutic agents which are derivatives of phthalazine allan leslie ham | |
| JPS5398991A (en) | 77acylamidee33sephemm44carboxylate unsaturated derivatives and process for preparing same | |
| ZA781511B (en) | Process for therapeutic treatment | |
| JPS5395917A (en) | Process for preparing nitrosourea derivative of glucopyranose | |
| GB2005253B (en) | Process for the preparation of p-benzoquinone diketals | |
| GB2000142B (en) | Process for the preparation of organo-magnesium complexes | |
| PT67743A (en) | Preparation of therapeutic agents | |
| JPS53130696A (en) | Azomethine derivative of liphamycine sv and process for preparing same | |
| PT68735A (en) | Process for preparing therapeutic agents for treatment of hypertension | |
| ZA786299B (en) | Process for the preparation of 3-iodo-and bromorifamycin s | |
| CS194835B2 (en) | Process for preparing active component of antinefrolithiatic agent | |
| GB2001625B (en) | Process for preparation of 3-acylamino-4-homoisotwistane | |
| PT67617B (en) | Process for preparing of azotizinone derivatives | |
| IL52413A (en) | Process for the preparazione of 5-chloro-6-sulfamyl-isoindolinone derivatives | |
| CS190339B2 (en) | Process for preparing derivatives of sulphonyl-benzimidazole | |
| EG13240A (en) | Process for preparing of pharmacologically active compounds | |
| DE2860746D1 (en) | Process for the preparation of 3-bromomethyl-3-cephem-sulphoxide derivatives |